Possible anticholinesterase-like effects of trans(-)  8  and -  9 tetrahydrocannabinol as observed in the general motor activity of mice.
D000166:Acridines / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001578:Benzopyrans / Q000494:pharmacology; D002188:Cannabis / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors; D013759:Dronabinol / Q000494:pharmacology; D004336:Drug Antagonism; D004338:Drug Combinations; D004357:Drug Synergism; D006016:Glycolates / Q000494:pharmacology; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D010424:Pentobarbital / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology
D000166:Acridines; D001578:Benzopyrans; D002800:Cholinesterase Inhibitors; D004338:Drug Combinations; D006016:Glycolates; D010880:Piperidines; D011759:Pyrrolidines; D013759:Dronabinol; D010830:Physostigmine; D012601:Scopolamine; D010424:Pentobarbital